Patrick Donnelly

Patrick Donnelly

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

October 16, 2018
Outdated Facilities – Bring Back the ‘c’ in cGMP
Bringing the ‘c’ in the cGMP status back into your facility, processes, or procedures… Read More
September 14, 2018
Data Integrity: 5 Ways to be GxP Compliant
Are you always ready to be inspected for your (GxP) activities in your facility? Read More
September 5, 2018
Industry Poll: What are the Leading Challenges with GMP Auditing?
After our recent poll, ProPharma Group's experts analyzed the responses to provide insight into… Read More
More Articles

UPCOMING Events

November 02, 2018
APCR Annual Meeting 2018
Join us at the University of North Florida on Friday, November 2 for APCR’s 2018 Annual Meeting being held ... Read More
November 04, 2018
ISPE Annual 2018
The 2018 ISPE Annual Meeting & Expo will focus on excellence, modernization, and harmonization in pharma... Read More
November 04, 2018
AAPS Annual Meeting 2018 – PharmSci 360
AAPS PharmSci 360 will combine all the energy of a large scientific conference with the intimacy of a small ni... Read More
All Events
Contact Us